This hypothesis stemmed from the observation that the PDAC patients with high MSLN expression in tumor biopsies showed unusually low levels of MSLN in the bloodstream, suggesting that shed MSLN was somehow retained within the TME. This evidence concerns the gene MSLN and neoplasm.